The impact of idiopathic pulmonary fibrosis on the airway length per generation in the human lung

V. Geudens (Leuven, Belgium), C. Aelbrecht (Leuven, Belgium), J. Kaes (Leuven, Belgium), J. Van Slambrouck (Leuven, Belgium), T. Goos (Leuven, Belgium), A. Vanstapel (Leuven, Belgium), G. Aerts (Leuven, Belgium), I. Gyselinck (Leuven, Belgium), L. J. De Sadeleer (Leuven, Belgium), S. E. Verleden (Leuven, Belgium), G. M. Verleden (Leuven, Belgium), W. Janssens (Leuven, Belgium), R. Vos (Leuven, Belgium), L. J. Ceulemans (Leuven, Belgium), G. Gayan-Ramirez (Leuven, Belgium), B. M. Vanaudenaerde (Leuven, Belgium), W. A. Wuyts (Leuven, Belgium)

Source: Virtual Congress 2021 – Translational and other aspects of idiopathic interstitial pneumonia
Session: Translational and other aspects of idiopathic interstitial pneumonia
Session type: E-poster
Number: 3284

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
V. Geudens (Leuven, Belgium), C. Aelbrecht (Leuven, Belgium), J. Kaes (Leuven, Belgium), J. Van Slambrouck (Leuven, Belgium), T. Goos (Leuven, Belgium), A. Vanstapel (Leuven, Belgium), G. Aerts (Leuven, Belgium), I. Gyselinck (Leuven, Belgium), L. J. De Sadeleer (Leuven, Belgium), S. E. Verleden (Leuven, Belgium), G. M. Verleden (Leuven, Belgium), W. Janssens (Leuven, Belgium), R. Vos (Leuven, Belgium), L. J. Ceulemans (Leuven, Belgium), G. Gayan-Ramirez (Leuven, Belgium), B. M. Vanaudenaerde (Leuven, Belgium), W. A. Wuyts (Leuven, Belgium). The impact of idiopathic pulmonary fibrosis on the airway length per generation in the human lung. 3284

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Are the gains due to pulmonary rehabilitation in idiopathic pulmonary fibrosis and other interstitial lung diseases the same?
Source: Virtual Congress 2020 – The multiple facets of pulmonary rehabilitation and chronic respiratory care
Year: 2020


Titrated oxygen requirement and prognostication in idiopathic pulmonary fibrosis
Source: Eur Respir J 2012; 39: 359-365
Year: 2012



The difference of lung mechanics and chest kinematics in pulmonary rehabilitation of interstitial lung diseases versus idiopathic pulmonary fibrosis
Source: International Congress 2019 – Hot topics in assessment and care for chronic lung diseases
Year: 2019

Aquoaporin-1 expression in idiopathic pulmonary fibrosis
Source: Annual Congress 2013 –Diffuse pulmonary fibrosis
Year: 2013


Pulmonary function measures predict mortality differently in IPF versus combined pulmonary fibrosis and emphysema
Source: Eur Respir J 2011; 37: 176-183
Year: 2011



The similarity and difference of pathology of pulmonary arterioles in COPD and idiopathic lung fibrosis (IPF)
Source: Annual Congress 2010 - Pulmonary circulation I
Year: 2010

The epidemiology of idiopathic pulmonary fibrosis and interstitial lung diseases at risk of a progressive-fibrosing phenotype
Source: Eur Respir Rev, 27 (150) 180077; 10.1183/16000617.0077-2018
Year: 2018



Bacterial load in chronic obstructive pulmonary disease and its relationship with airway inflammation and lung function
Source: Annual Congress 2011 - Role of infection in exacerbations of COPD
Year: 2011


Coexistent pulmonary emphysema delays the decrease in vital capacity in patients with idiopathic pulmonary fibrosis
Source: Annual Congress 2008 - Miscellaneous aspects of interstitial lung disease
Year: 2008


Improving airway clearance in cystic fibrosis lung disease
Source: Eur Respir Monogr 2014; 64: 169-187
Year: 2014


The impact of emphysema in pulmonary fibrosis
Source: Eur Respir Rev 2013; 22: 153-157
Year: 2013



Analysis of the lung microbiota in healthy dogs and in canine idiopathic pulmonary fibrosis, a possible spontaneous model for human IPF.
Source: International Congress 2018 – Pulmonary fibrosis: from models to patients
Year: 2018

Significance of small airway obstruction in patients with idiopathic pulmonary fibrosis.
Source: International Congress 2019 – Innovations in idiopathic pulmonary fibrosis
Year: 2019

Airway basal cell involvement in idiopathic pulmonary fibrosis
Source: Virtual Congress 2020 – (Re-)discovering the small airway epithelium in COVID-19, fibrosing lung diseases and pulmonary regeneration
Year: 2020


Beyond idiopathic pulmonary fibrosis: the world of progressive-fibrosing interstitial lung disease
Source: Eur Respir Rev, 27 (150) 180110; 10.1183/16000617.0110-2018
Year: 2018



Serum surfactant protein D (SP-D) and annual decline of diffusion capacity are prognostic factors for combined pulmonary fibrosis with emphysema (CPFE) in idiopathic pulmonary fibrosis (IPF)
Source: Annual Congress 2013 –Clinical respiratory physiology in different diseases
Year: 2013


Increased polysialylation in lung tissue of patients with idiopathic pulmonary fibrosis
Source: Annual Congress 2011 - Cell biology of lung disease
Year: 2011


Airway length per generation in the human healthy lung and the impact of COPD
Source: Virtual Congress 2021 – Management of chronic cough and obstructive diseases
Year: 2021


Changes in the small airways in idiopathic pulmonary fibrosis
Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis and rarities
Year: 2013